Integra Lifesciences Holdings (IART) Tops Q4 EPS by 9c; Guides FY12 EPS, Revs
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Join SI Premium – FREE
Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.72, $0.09 better than the analyst estimate of $0.63. Revenue for the quarter came in at $203.5 million versus the consensus estimate of $202 million.
Integra Lifesciences Holdings sees FY2012 EPS of $2.93-$3.06, versus the consensus of $3.04. Integra Lifesciences Holdings sees FY2012 revenue of $820-$835 million, versus the consensus of $832.1 million.
For earnings history and earnings-related data on Integra Lifesciences Holdings (IART) click here.
Integra Lifesciences Holdings sees FY2012 EPS of $2.93-$3.06, versus the consensus of $3.04. Integra Lifesciences Holdings sees FY2012 revenue of $820-$835 million, versus the consensus of $832.1 million.
For earnings history and earnings-related data on Integra Lifesciences Holdings (IART) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
- UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
